pcDNA3.0-Magneto2.0-p2A-mCherry Citations (3)

Originally described in: Genetically targeted magnetic control of the nervous system.
Wheeler MA, Smith CJ, Ottolini M, Barker BS, Purohit AM, Grippo RM, Gaykema RP, Spano AJ, Beenhakker MP, Kucenas S, Patel MK, Deppmann CD, Guler AD Nat Neurosci. 2016 Mar 7. doi: 10.1038/nn.4265. PubMed Journal

Articles Citing pcDNA3.0-Magneto2.0-p2A-mCherry

Showing 1 to 3 of 3 entries

Show entries

Search table:

Articles
An Innovative Mitochondrial-targeted Gene Therapy for Cancer Treatment. Chen K, Ernst P, Kim S, Si Y, Varadkar T, Ringel MD, Liu XM, Zhou L. bioRxiv [Preprint]. 2024 Mar 27:2024.03.24.584499. doi: 10.1101/2024.03.24.584499. PubMed
Magneto is ineffective in controlling electrical properties of cerebellar Purkinje cells. Xu FX, Zhou L, Wang XT, Jia F, Ma KY, Wang N, Lin L, Xu FQ, Shen Y. Nat Neurosci. 2020 Sep;23(9):1041-1043. doi: 10.1038/s41593-019-0475-3. Epub 2019 Sep 30. PubMed
Assessing the utility of Magneto to control neuronal excitability in the somatosensory cortex. Kole K, Zhang Y, Jansen EJR, Brouns T, Bijlsma A, Calcini N, Yan X, Lantyer ADS, Celikel T. Nat Neurosci. 2020 Sep;23(9):1044-1046. doi: 10.1038/s41593-019-0474-4. Epub 2019 Sep 30. PubMed

If you have published an article using this material, please email us at help@addgene.org to have your article added to this page.